222 related articles for article (PubMed ID: 2159538)
1. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.
Ward RL; Knowlton DR; Greenberg HB; Schiff GM; Bernstein DI
J Virol; 1990 Jun; 64(6):2687-91. PubMed ID: 2159538
[TBL] [Abstract][Full Text] [Related]
2. Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.
Ward RL; McNeal MM; Sander DS; Greenberg HB; Bernstein DI
J Virol; 1993 Jan; 67(1):464-8. PubMed ID: 8416378
[TBL] [Abstract][Full Text] [Related]
3. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR
Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523
[TBL] [Abstract][Full Text] [Related]
4. Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4.
Clark HF; Lawley D; Shrager D; Jean-Guillaume D; Offit PA; Whang SY; Eiden JJ; Bennett PS; Kaplan KM; Shaw AR
Pediatr Infect Dis J; 2004 Mar; 23(3):206-11. PubMed ID: 15014293
[TBL] [Abstract][Full Text] [Related]
5. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
6. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
Gorrell RJ; Bishop RF
J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination.
Taniguchi K; Urasawa T; Kobayashi N; Ahmed MU; Adachi N; Chiba S; Urasawa S
J Clin Microbiol; 1991 Mar; 29(3):483-7. PubMed ID: 1709946
[TBL] [Abstract][Full Text] [Related]
8. Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.
Gorrell RJ; Bishop RF
Clin Diagn Lab Immunol; 1997 Sep; 4(5):509-14. PubMed ID: 9302196
[TBL] [Abstract][Full Text] [Related]
9. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.
Clark HF; Offit PA; Ellis RW; Eiden JJ; Krah D; Shaw AR; Pichichero M; Treanor JJ; Borian FE; Bell LM; Plotkin SA
J Infect Dis; 1996 Sep; 174 Suppl 1():S73-80. PubMed ID: 8752294
[TBL] [Abstract][Full Text] [Related]
10. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.
Ward RL; Knowlton DR; Schiff GM; Hoshino Y; Greenberg HB
J Virol; 1988 May; 62(5):1543-9. PubMed ID: 3357205
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of VP4/VP7 reassortant swine rotaviruses derived from Gottfried and OSU parental strains.
Hesse RA; Couture LP; Ellsworth SR; Duhamel GE; Lu W; Dickinson EO; Benfield DA
Am J Vet Res; 1993 Oct; 54(10):1623-9. PubMed ID: 8250387
[TBL] [Abstract][Full Text] [Related]
12. Studies on the role of VP4 of G serotype 10 rotavirus (B223) in the induction of the heterologous immune response in calves.
Xu Z; Woode GN
Virology; 1993 Sep; 196(1):294-7. PubMed ID: 8395118
[TBL] [Abstract][Full Text] [Related]
13. WC3 reassortant vaccines in children.
Clark HF; Offit PA; Ellis RW; Krah D; Shaw AR; Eiden JJ; Pichichero M; Treanor JJ
Arch Virol Suppl; 1996; 12():187-98. PubMed ID: 9015115
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3.
Ciarlet M; Hyser JM; Estes MK
Virus Genes; 2002 Mar; 24(2):107-18. PubMed ID: 12018701
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
Arch Virol; 1991; 121(1-4):153-62. PubMed ID: 1722090
[TBL] [Abstract][Full Text] [Related]
16. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity.
Hoshino Y; Jones RW; Chanock RM; Kapikian AZ
J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947
[TBL] [Abstract][Full Text] [Related]
17. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.
Chen DY; Estes MK; Ramig RF
J Virol; 1992 Jan; 66(1):432-9. PubMed ID: 1370090
[TBL] [Abstract][Full Text] [Related]
18. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.
Offit PA; Clark HF; Blavat G; Greenberg HB
J Virol; 1986 Nov; 60(2):491-6. PubMed ID: 3021983
[TBL] [Abstract][Full Text] [Related]
19. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
Hoshino Y; Saif LJ; Sereno MM; Chanock RM; Kapikian AZ
J Virol; 1988 Mar; 62(3):744-8. PubMed ID: 2828669
[TBL] [Abstract][Full Text] [Related]
20. Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.
Gorziglia M; Larralde G; Kapikian AZ; Chanock RM
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7155-9. PubMed ID: 1698292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
